Gregorc V - Search Results

1

Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.

Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M. Ludovini V, et al. Among authors: gregorc v. Lung Cancer. 2004 Oct;46(1):77-85. doi: 10.1016/j.lungcan.2004.03.018. Lung Cancer. 2004. PMID: 15364135

2

KRAS in NSCLC: State of the Art and Future Perspectives.

Cascetta P, Marinello A, Lazzari C, Gregorc V, Planchard D, Bianco R, Normanno N, Morabito A. Cascetta P, et al. Among authors: gregorc v. Cancers (Basel). 2022 Nov 4;14(21):5430. doi: 10.3390/cancers14215430. Cancers (Basel). 2022. PMID: 36358848 Free PMC article. Review.

3

Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patients with solid malignancies.

Lazzari C, Yacoub MR, Campochiaro C, Bulotta A, Palumbo D, Ogliari FR, Dagna L, Marchesi S, Ponzoni M, Gregorc V. Lazzari C, et al. Among authors: gregorc v. Front Oncol. 2023 Jan 26;13:1079034. doi: 10.3389/fonc.2023.1079034. eCollection 2023. Front Oncol. 2023. PMID: 36776300 Free PMC article.

4

hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.

Trono P, Tocci A, Palermo B, Di Carlo A, D'Ambrosio L, D'Andrea D, Di Modugno F, De Nicola F, Goeman F, Corleone G, Warren S, Paolini F, Panetta M, Sperduti I, Baldari S, Visca P, Carpano S, Cappuzzo F, Russo V, Tripodo C, Zucali P, Gregorc V, Marchesi F, Nistico P. Trono P, et al. Among authors: gregorc v. J Immunother Cancer. 2023 Aug;11(8):e006913. doi: 10.1136/jitc-2023-006913. J Immunother Cancer. 2023. PMID: 37612043 Free PMC article.

5

Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib.

Lazzari C, Pecciarini L, Doglioni C, Pedica F, Gajate AMS, Bulotta A, Gregorc V, Cangi MG. Lazzari C, et al. Among authors: gregorc v. Front Oncol. 2022 Nov 7;12:1038774. doi: 10.3389/fonc.2022.1038774. eCollection 2022. Front Oncol. 2022. PMID: 36419889 Free PMC article.

6

Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic.

Valsecchi D, Porcu L, Khater A, Battista RA, Giordano L, Cascinu S, Assanelli A, Lazzari C, Gregorc V, Mirabile A. Valsecchi D, et al. Among authors: gregorc v. Cancers (Basel). 2023 Feb 15;15(4):1240. doi: 10.3390/cancers15041240. Cancers (Basel). 2023. PMID: 36831581 Free PMC article.

7

Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer.

Gregorc V, Ludovini V, Pistola L, Darwish S, Floriani I, Bellezza G, Sidoni A, Cavaliere A, Scheibel M, De Angelis V, Bucciarelli E, Tonato M. Gregorc V, et al. Lung Cancer. 2003 Jan;39(1):41-8. doi: 10.1016/s0169-5002(02)00391-4. Lung Cancer. 2003. PMID: 12499093

8

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.

Cappuzzo F, Selvaggi G, Gregorc V, Mazzoni F, Betti M, Rita Migliorino M, Novello S, Maestri A, De Marinis F, Darwish S, De Angelis V, Nelli F, Bartolini S, Scagliotti GV, Tonato M, Crinò L. Cappuzzo F, et al. Among authors: gregorc v. Cancer. 2003 Jul 1;98(1):128-34. doi: 10.1002/cncr.11460. Cancer. 2003. PMID: 12833465 Free article. Clinical Trial.

9

Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC.

Cappuzzo F, Gregorc V, Rossi E, Cancellieri A, Magrini E, Paties CT, Ceresoli G, Lombardo L, Bartolini S, Calandri C, de Rosa M, Villa E, Crino L. Cappuzzo F, et al. Among authors: gregorc v. J Clin Oncol. 2003 Jul 15;21(14):2658-63. doi: 10.1200/JCO.2003.01.039. J Clin Oncol. 2003. PMID: 12860941 Clinical Trial.

10

The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer.

Gregorc V, Darwish S, Ludovini V, Pistola L, De Angelis V, Mihaylova Z, Bellezza G, Sidoni A, Cavaliere A, Bucciarelli E, Massaro G, Tonato M. Gregorc V, et al. Lung Cancer. 2003 Dec;42(3):275-81. doi: 10.1016/j.lungcan.2003.07.003. Lung Cancer. 2003. PMID: 14644514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters